sspe
Table of Contents
Subacute sclerosing panencephalitis (SSPE)
Introduction
- subacute sclerosing panencephalitis is a progressive, fatal brain disorder caused by a persistent measles virus infection resulting from a mutated, persistent measles virus residing in the central nervous system
Epidemiology
- overall prevalence is estimated at 4 to 11 cases per 100,000 people who contract natural measles but risk is much higher the younger the patient when contracting measles:
- risk soars dramatically to roughly 1 in 600 for infants who get measles before their first birthday
- risk is approximately 1 in 1,700 to 1 in 3,300 when children contract measles between age 1 and 5 years
- risk averages out to about 1 in 10,000 to 1 in 25,000 cases across all age groups combined
Clinical features
- develops slowly, typically 6 to 8 years after an initial, early childhood measles infection
- it is relentlessly progressive and almost always fatal within 1 to 3 years
Diagnosis
-
- very high measles antibody titers
- EEG:
- features periodic high-amplitude complexes
DDx
- can sometimes mimic leukoencephalopathy (ADEM) in its early or rapidly deteriorating stages
Rx
- treating SSPE with immunosuppressive therapies meant for ADEM can dangerously accelerate the viral disease and prove fatal
sspe.txt · Last modified: 2026/09/02 02:34 by wh